Location History:
- Clarksburg, MD (US) (2008 - 2015)
- Cabin John, MD (US) (2014 - 2017)
Company Filing History:
Years Active: 2008-2017
Title: Christopher Rankin: Innovator in Antibody Engineering
Introduction
Christopher Rankin is a notable inventor based in Clarksburg, MD, who has significantly contributed to the field of antibody engineering. With a total of 11 patents, his work focuses on advancing therapeutic methods for diseases associated with CD20 expression and enhancing the efficacy of immunoglobulins.
Latest Patents
Among his latest patents is the innovative combination of FcγRIIB-specific antibodies and CD20-specific antibodies and methods of use thereof. This invention aims to treat, prevent, manage, or ameliorate symptoms associated with B cell-related diseases or inflammatory disorders. The methods encompass administering a combination of antibodies that bind to both FcγRIIB and CD20, thereby providing a potent therapeutic option. Another significant patent is for the identification and engineering of antibodies with variant Fc regions. This invention involves molecules that comprise a modified Fc region with enhanced binding affinity, making them particularly effective in treating ailments where improved effector cell function is desired, such as in cancer and infectious diseases.
Career Highlights
Christopher Rankin's career has been marked by his role at Macrogenics, Inc., where he focuses on developing cutting-edge therapeutic solutions through innovative antibody design. His work has gained recognition within the industry for its potential to improve treatment outcomes for patients.
Collaborations
Throughout his career, Rankin has collaborated with other experts in his field, including Jeffrey B. Stavenhagen and Sergey Gorlatov. These partnerships have fostered an environment of innovation and have contributed to the successful development of his groundbreaking patents.
Conclusion
As an inventor, Christopher Rankin continues to push the boundaries of antibody engineering and therapeutic application. His patents not only exemplify his dedication to the advancement of medical science but also highlight the importance of collaboration and innovation in creating effective treatments for complex diseases.